600671 Stock Overview
Engages in the pharmaceutical manufacturing and drug distribution businesses in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.80 |
| 52 Week High | CN¥12.41 |
| 52 Week Low | CN¥5.85 |
| Beta | 0.28 |
| 11 Month Change | 35.73% |
| 3 Month Change | 48.26% |
| 1 Year Change | -7.11% |
| 33 Year Change | 17.65% |
| 5 Year Change | -20.58% |
| Change since IPO | 189.19% |
Recent News & Updates
What Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's (SHSE:600671) 27% Share Price Gain Is Not Telling You
Oct 25
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHSE:600671) Investors Are Less Pessimistic Than Expected
Jul 18Shareholder Returns
| 600671 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 15.3% | -1.9% | -1.2% |
| 1Y | -7.1% | -5.0% | 3.1% |
Return vs Industry: 600671 underperformed the CN Pharmaceuticals industry which returned -4.9% over the past year.
Return vs Market: 600671 underperformed the CN Market which returned 5.7% over the past year.
Price Volatility
| 600671 volatility | |
|---|---|
| 600671 Average Weekly Movement | 6.2% |
| Pharmaceuticals Industry Average Movement | 7.1% |
| Market Average Movement | 7.8% |
| 10% most volatile stocks in CN Market | 12.0% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 600671 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600671's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 380 | Bo Liu | www.hztmyy.com |
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces and sells medicines and related health care products, including tablets, granules, pills, mixtures, oral liquids, syrups, eye drops, pills, soft capsules, tablets, granules, and other health foods. It is also involved in the sale of menthol and peppermint oil raw materials, Chinese medicine formulas, Chinese medicine pieces, fresh herbs, etc.; and provision of professional medical services, such as valet decoction and distribution, as well as Chinese medicine diagnosis and treatment services.
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Fundamentals Summary
| 600671 fundamental statistics | |
|---|---|
| Market cap | CN¥1.19b |
| Earnings (TTM) | -CN¥14.51m |
| Revenue (TTM) | CN¥160.35m |
7.4x
P/S Ratio-82.2x
P/E RatioIs 600671 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600671 income statement (TTM) | |
|---|---|
| Revenue | CN¥160.35m |
| Cost of Revenue | CN¥103.24m |
| Gross Profit | CN¥57.11m |
| Other Expenses | CN¥71.62m |
| Earnings | -CN¥14.51m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 35.62% |
| Net Profit Margin | -9.05% |
| Debt/Equity Ratio | 160.6% |
How did 600671 perform over the long term?
See historical performance and comparison